Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
1
pubmed:dateCreated
2009-1-14
pubmed:abstractText
Several antimalarials can cause significant prolongation of the electrocardiograph QT interval, which can be associated with an increased risk of potentially lethal ventricular arrhythmias. High doses of artemether and artemotil have been associated with QT prolongation in dogs, raising the possibility of a class effect with the artemisinin derivatives. Serial electrocardiograms were recorded, and QTc interval was calculated before and after administration of artesunate by intravenous injection in patients with severe falciparum malaria in Bangladesh. Of 21 adult patients with severe malaria enrolled, 8 (38%) died. The mean QTc interval was unaffected by bolus intravenous artesunate (2.4 mg/kg). In two patients, the QTc interval exceeded 0.5 seconds, but in both cases, an alternative explanation was plausible. No effect was observed on the JTc or PR interval, QRS width, blood pressure, or heart rate. Intravenous artesunate does not have significant cardiovascular effects in patients with severe falciparum malaria.
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/19141850-10348227, http://linkedlifedata.com/resource/pubmed/commentcorrection/19141850-10456492, http://linkedlifedata.com/resource/pubmed/commentcorrection/19141850-10661809, http://linkedlifedata.com/resource/pubmed/commentcorrection/19141850-10674679, http://linkedlifedata.com/resource/pubmed/commentcorrection/19141850-11037786, http://linkedlifedata.com/resource/pubmed/commentcorrection/19141850-11037787, http://linkedlifedata.com/resource/pubmed/commentcorrection/19141850-12736279, http://linkedlifedata.com/resource/pubmed/commentcorrection/19141850-14678346, http://linkedlifedata.com/resource/pubmed/commentcorrection/19141850-1519533, http://linkedlifedata.com/resource/pubmed/commentcorrection/19141850-16125588, http://linkedlifedata.com/resource/pubmed/commentcorrection/19141850-16231954, http://linkedlifedata.com/resource/pubmed/commentcorrection/19141850-16760509, http://linkedlifedata.com/resource/pubmed/commentcorrection/19141850-17109296, http://linkedlifedata.com/resource/pubmed/commentcorrection/19141850-2170562, http://linkedlifedata.com/resource/pubmed/commentcorrection/19141850-6751085, http://linkedlifedata.com/resource/pubmed/commentcorrection/19141850-6765851, http://linkedlifedata.com/resource/pubmed/commentcorrection/19141850-7943542, http://linkedlifedata.com/resource/pubmed/commentcorrection/19141850-8053022, http://linkedlifedata.com/resource/pubmed/commentcorrection/19141850-8096959, http://linkedlifedata.com/resource/pubmed/commentcorrection/19141850-8649493, http://linkedlifedata.com/resource/pubmed/commentcorrection/19141850-9790416, http://linkedlifedata.com/resource/pubmed/commentcorrection/19141850-9790421
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
AIM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Jan
pubmed:issn
1476-1645
pubmed:author
pubmed:issnType
Electronic
pubmed:volume
80
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
126-32
pubmed:dateRevised
2010-9-23
pubmed:meshHeading
pubmed:year
2009
pubmed:articleTitle
Does artesunate prolong the electrocardiograph QT interval in patients with severe malaria?
pubmed:affiliation
Centre for Clinical Vaccinology and Tropical Medicine, Nuffield Department of Clinical Medicine, University of Oxford, Oxford, United Kingdom. richard@tropmedres.ac
pubmed:publicationType
Journal Article, Case Reports